NeoGenomics is the only publicly-traded pure-play laboratory testing service provider specifically focused on high revenue cancer genetics testing. Advances in technology and genetic research, combined with the complete sequencing of the human genome, have made sophisticated new scientific testing tools to diagnose and treat diseases possible. The company provides state of the art genetic testing at two facilities in Ft. Myers, Fla., and additional ones in Nashville, Tenn. and Irvine, Calif. NeoGenomics is fully certified to industry and government standards for genetics specimen testing nationwide.